Zymeworks ZYME
NASDAQ ZYME
$29.36 -0.54 (-1.81%)
As of: Sep 4, 2026 · 3:10 PM EDT

Zymeworks (ZYME) Market Capitalization (2021 - 2026)

Analysis

Zymeworks (ZYME) Market Capitalization (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.58 Bn 130.73 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.33 Bn 77.33 Bn 3.93 Bn
3 Argenx Se 63.43 Bn 58.24 Bn 1.37 Bn
4 Moderna 57.84 Bn 52.70 Bn 52.00 Mn
5 Revolution Medicines 44.01 Bn 44.01 Bn -
6 BeOne Medicines 39.93 Bn 34.83 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.47 Bn 32.16 Bn 992.69 Mn
8 Royalty Pharma 28.39 Bn 27.56 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Zymeworks 2.14 Bn 1.87 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.87 Bn
Mar 31, 2026 1.83 Bn
Dec 31, 2025 1.97 Bn
Sep 30, 2025 1.28 Bn
Jun 30, 2025 939.32 Mn
Mar 31, 2025 828.76 Mn
Dec 31, 2024 1.01 Bn
Sep 30, 2024 873.29 Mn
Jun 30, 2024 602.78 Mn
Mar 31, 2024 743.52 Mn
Dec 31, 2023 728.51 Mn
Sep 30, 2023 430.63 Mn
Jun 30, 2023 584.82 Mn
Mar 31, 2023 579.32 Mn
Dec 31, 2022 495.65 Mn
Sep 30, 2022 379.42 Mn
Jun 30, 2022 351.67 Mn
Mar 31, 2022 401.96 Mn
Dec 31, 2021 764.33 Mn
Sep 30, 2021 1.50 Bn